A randomized, double-blind study of a combination of amlodipine and irbesartan in patients with essential hypertension who insufficiently responded to irbesartan once daily

Authors
Category Primary study
Registry of TrialsJapan Pharmaceutical Information Center
Year 2009
INTERVENTION: Intervention name : amlodipine, irbesartan Dosage And administration of the intervention : oral CONDITION: Hypertension PRIMARY OUTCOME: Efficacy: Change in trough BP from baseline INCLUSION CRITERIA: Patients with essential hypertension who meet one of the following criteria a) Patients who are taking antihypertensive drugs b) Patients who are not taking any antihypertensive drugs and whose seated systolic blood pressure (SBP) is >=160 mmHg or whose diastolic blood pressure (DBP) is >=100 mmHg
Epistemonikos ID: 289b007c77f76e2383dc0380fd6bf4248d5f64cd
First added on: Aug 22, 2024